期刊
IUBMB LIFE
卷 61, 期 7, 页码 723-730出版社
WILEY
DOI: 10.1002/iub.198
关键词
CDCP1; Src; integrin; cancer; leukemia
资金
- Australian National Health and Medical Research Council [339732]
- National Institutes of Health [CA55852, CA105412]
In the last few years dysregulated expression of the cell surface glycoprotein CUB domain-containing protein 1. (CDCP1) has been associated with several cancers and this cell surface molecule has been recognized both as a tumor marker and as a potential target to disrupt progression of cancer. Here we summarize what is known about CDCP1 including its structural features, expression in normal and cancerous tissues, and the in vitro experiments and studies in animal models that have provided the key insights into its potential role in tumor formation and metastasis in humans. We conclude by highlighting opportunities and challenges in targeting CDCP1 in cancer. (C) 2009 IUBMB IUBMB Life, 61(7): 723-730, 2009
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据